BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 27919191)

  • 1. Phytotherapeutic approach: a new hope for polycyclic aromatic hydrocarbons induced cellular disorders, autophagic and apoptotic cell death.
    Das DN; Panda PK; Naik PP; Mukhopadhyay S; Sinha N; Bhutia SK
    Toxicol Mech Methods; 2017 Jan; 27(1):1-17. PubMed ID: 27919191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polycyclic Aromatic Hydrocarbons: Part I. Exposure.
    Ifegwu OC; Anyakora C
    Adv Clin Chem; 2015; 72():277-304. PubMed ID: 26471085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influences of polycyclic aromatic hydrocarbon on the epigenome toxicity and its applicability in human health risk assessment.
    Das DN; Ravi N
    Environ Res; 2022 Oct; 213():113677. PubMed ID: 35714684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of the aryl hydrocarbon receptor is the major toxic mode of action of an organic extract of a reference urban dust particulate matter mixture: the role of polycyclic aromatic hydrocarbons.
    Andrysík Z; Vondráček J; Marvanová S; Ciganek M; Neča J; Pěnčíková K; Mahadevan B; Topinka J; Baird WM; Kozubík A; Machala M
    Mutat Res; 2011 Sep; 714(1-2):53-62. PubMed ID: 21762708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polycyclic aromatic hydrocarbons: from metabolism to lung cancer.
    Moorthy B; Chu C; Carlin DJ
    Toxicol Sci; 2015 May; 145(1):5-15. PubMed ID: 25911656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polycyclic aromatic hydrocarbons modulate cell proliferation in rat hepatic epithelial stem-like WB-F344 cells.
    Chramostová K; Vondrácek J; Sindlerová L; Vojtesek B; Kozubík A; Machala M
    Toxicol Appl Pharmacol; 2004 Apr; 196(1):136-48. PubMed ID: 15050415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of the aryl hydrocarbon receptor-mediated activities of polycyclic aromatic hydrocarbons in a human cell-based reporter gene assay.
    Vondráček J; Pěnčíková K; Neča J; Ciganek M; Grycová A; Dvořák Z; Machala M
    Environ Pollut; 2017 Jan; 220(Pt A):307-316. PubMed ID: 27692884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of human cytochrome P450 1A1-, 1A2-, and 1B1-mediated activation of procarcinogens to genotoxic metabolites by polycyclic aromatic hydrocarbons.
    Shimada T; Guengerich FP
    Chem Res Toxicol; 2006 Feb; 19(2):288-94. PubMed ID: 16485905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CYP1A induction and human risk assessment: an evolving tale of in vitro and in vivo studies.
    Ma Q; Lu AY
    Drug Metab Dispos; 2007 Jul; 35(7):1009-16. PubMed ID: 17431034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polycyclic aromatic hydrocarbon-inducible DNA adducts: evidence by 32P-postlabeling and use of knockout mice for Ah receptor-independent mechanisms of metabolic activation in vivo.
    Kondraganti SR; Fernandez-Salguero P; Gonzalez FJ; Ramos KS; Jiang W; Moorthy B
    Int J Cancer; 2003 Jan; 103(1):5-11. PubMed ID: 12455047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The aryl hydrocarbon receptor-dependent deregulation of cell cycle control induced by polycyclic aromatic hydrocarbons in rat liver epithelial cells.
    Andrysík Z; Vondrácek J; Machala M; Krcmár P; Svihálková-Sindlerová L; Kranz A; Weiss C; Faust D; Kozubík A; Dietrich C
    Mutat Res; 2007 Feb; 615(1-2):87-97. PubMed ID: 17141280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beyond the obvious: Environmental health implications of polar polycyclic aromatic hydrocarbons.
    Idowu O; Semple KT; Ramadass K; O'Connor W; Hansbro P; Thavamani P
    Environ Int; 2019 Feb; 123():543-557. PubMed ID: 30622079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human CD34-positive hematopoietic stem cells constitute targets for carcinogenic polycyclic aromatic hydrocarbons.
    van Grevenynghe J; Bernard M; Langouet S; Le Berre C; Fest T; Fardel O
    J Pharmacol Exp Ther; 2005 Aug; 314(2):693-702. PubMed ID: 15860575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exposure to polycyclic aromatic hydrocarbons: bulky DNA adducts and cellular responses.
    Henkler F; Stolpmann K; Luch A
    Exp Suppl; 2012; 101():107-31. PubMed ID: 22945568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of the aryl hydrocarbon receptor pathway in mediating synergistic developmental toxicity of polycyclic aromatic hydrocarbons to zebrafish.
    Billiard SM; Timme-Laragy AR; Wassenberg DM; Cockman C; Di Giulio RT
    Toxicol Sci; 2006 Aug; 92(2):526-36. PubMed ID: 16687390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential action of chlorinated polycyclic aromatic hydrocarbons on aryl hydrocarbon receptor-mediated signaling in breast cancer cells.
    Ohura T; Morita M; Kuruto-Niwa R; Amagai T; Sakakibara H; Shimoi K
    Environ Toxicol; 2010 Apr; 25(2):180-7. PubMed ID: 19365803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of CYP1A1, CYP1A2, and CYP1B1 mRNAs by nitropolycyclic aromatic hydrocarbons in various human tissue-derived cells: chemical-, cytochrome P450 isoform-, and cell-specific differences.
    Iwanari M; Nakajima M; Kizu R; Hayakawa K; Yokoi T
    Arch Toxicol; 2002 Jun; 76(5-6):287-98. PubMed ID: 12107646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ligand-Specific Transcriptional Mechanisms Underlie Aryl Hydrocarbon Receptor-Mediated Developmental Toxicity of Oxygenated PAHs.
    Goodale BC; La Du J; Tilton SC; Sullivan CM; Bisson WH; Waters KM; Tanguay RL
    Toxicol Sci; 2015 Oct; 147(2):397-411. PubMed ID: 26141390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polycyclic aromatic hydrocarbons in binary mixtures modulate the efficiency of benzo[a]pyrene to form DNA adducts in human cells.
    Tarantini A; Maître A; Lefèbvre E; Marques M; Rajhi A; Douki T
    Toxicology; 2011 Jan; 279(1-3):36-44. PubMed ID: 20849910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developmental toxicity of 4-ring polycyclic aromatic hydrocarbons in zebrafish is differentially dependent on AH receptor isoforms and hepatic cytochrome P4501A metabolism.
    Incardona JP; Day HL; Collier TK; Scholz NL
    Toxicol Appl Pharmacol; 2006 Dec; 217(3):308-21. PubMed ID: 17112560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.